Form 4 for FLNT Fluent, Inc.
Accepted 2025-05-21 00:00:00 ET · period of report 2025-05-19 · accession 0001104659-25-051611 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-05-21 | 2025-05-19 | FLNT | Frost Gamma Investments Trust | 10% | F - Tax | $2.13 | -212 | 5.75M | -0.0% | -$451.56 |
| DI | 2025-05-21 | 2025-05-19 | FLNT | Frost Gamma Investments Trust | 10% | J - Other | $0.00 | +909.3K | 5.75M | +19% | $0 |
| DMI | 2025-05-21 | 2025-05-19 | FLNT | Frost Gamma Investments Trust | 10% | A - Grant | $1.10 | +1.82M | 909.3K | New | +$2.00M |
| DI | 2025-05-21 | 2025-05-19 | FLNT | Frost Gamma Investments Trust | 10% | D - Sale to Iss | $2.20 | +909.3K | 0 | New | +$2.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-19 | F | D | 212 | $2.13 | 5,747,010 | I Held by Frost Gamma Investments Trust | — | — | (F1) These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2025-05-19 | J | A | 909,297 | $0.00 | 5,747,222 | I Held by Frost Gamma Investments Trust | — | — | (F1) These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 3 | Derivative | Warrants | 2025-05-19 | A | A | 909,297 | $0.00 | 909,297 | I Held by Frost Gamma Investments Trust | $2.20 · 2025-05-19 to — | 909,297 Common Stock | (F1) These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. (F4) The Warrants will expire three years from the date of issuance. |
| 4 | Derivative | Pre-Funded Warrants | 2025-05-19 | D | A | 909,297 | $2.20 | 0 | I Held by Frost Gamma Investments Trust | $0.00 · 2025-05-19 to — | 909,297 Common Stock | (F1) These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. (F3) The Pre-Funded Warrants were immediately exercisable when issued and were exercised on May 19, 2025. (F2) The Pre-Funded Warrants expire when exercised in full. |
| 5 | Derivative | Pre-Funded Warrants | 2025-05-19 | A | A | 909,297 | $2.20 | 909,297 | I Held by Frost Gamma Investments Trust | $0.00 · 2025-05-19 to — | 909,297 Common Stock | (F1) These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. (F3) The Pre-Funded Warrants were immediately exercisable when issued and were exercised on May 19, 2025. (F2) The Pre-Funded Warrants expire when exercised in full. |